FDA Counter-Terrorism Will Take Precedence Over Rx Approvals In Crisis
Executive Summary
Counter-terrorism activities will take priority over drug approvals at FDA in the event of another attack, Center for Drug Evaluation & Research Director Janet Woodcock, MD, said